Edition:
India

Becton Dickinson and Co (BDX.N)

BDX.N on New York Stock Exchange

236.71USD
22 Jan 2018
Change (% chg)

$2.20 (+0.94%)
Prev Close
$234.51
Open
$234.07
Day's High
$236.74
Day's Low
$233.48
Volume
400,688
Avg. Vol
357,248
52-wk High
$236.74
52-wk Low
$169.23

Chart for

About

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of... (more)

Overall

Beta: 1.04
Market Cap(Mil.): $45,076.07
Shares Outstanding(Mil.): 227.57
Dividend: 0.73
Yield (%): 1.47

Financials

BRIEF-BD Statement On FDA Warning Letter For Preanalytical Systems Business Unit

* BD STATEMENT ON FDA WARNING LETTER FOR PREANALYTICAL SYSTEMS BUSINESS UNIT

12 Jan 2018

BRIEF-FDA Issues Warning Letter To Becton Dickinson & Co

* FDA WARNS BECTON DICKINSON & COMPANY OF SIGNIFICANT VIOLATIONS OF THE LAW AS PART OF ONGOING INVESTIGATION INTO LEAD TESTING ISSUES‍​

12 Jan 2018

Becton Dickinson's $24 billion takeover of C R Bard set to close after China nod

BEIJING China's commerce ministry said on Thursday that it has conditionally approved the takeover by U.S. medical equipment supplier Becton Dickinson of its U.S. peer C R Bard, paving the way for the $24 billion deal to close.

28 Dec 2017

UPDATE 1-Becton Dickinson's $24 bln takeover of C R Bard set to close after China nod

* Becton had said China approval was last hurdle for deal to close

28 Dec 2017

China commerce ministry conditionally approves Becton Dickinson-C R Bard merger

BEIJING China's commerce ministry said on Thursday that it has conditionally approved a merger between U.S. medical equipment supplier Becton Dickinson and its U.S. peer C R Bard .

28 Dec 2017

China commerce ministry conditionally approves Becton Dickinson-C R Bard merger

BEIJING, Dec 28 China's commerce ministry said on Thursday that it has conditionally approved a merger between U.S. medical equipment supplier Becton Dickinson and its U.S. peer C R Bard.

28 Dec 2017

Becton, Dickinson to divest two product lines for C R Bard buy: FTC

WASHINGTON U.S. medical equipment supplier Becton Dickinson and C R Bard have agreed to divest two product lines to satisfy U.S. Federal Trade Commission concerns their proposed $24 billion merger would negatively affect competition.

23 Dec 2017

UPDATE 1-Becton, Dickinson to divest two product lines for C R Bard buy -FTC

WASHINGTON, Dec 22 U.S. medical equipment supplier Becton Dickinson and C R Bard have agreed to divest two product lines to satisfy U.S. Federal Trade Commission concerns their proposed $24 billion merger would negatively affect competition.

23 Dec 2017

BRIEF-BD Issues Statement On FTC Clearance Of Bard Acquisition

* EXPECT BARD DEAL WILL CLOSE IN DECEMBER, PENDING APPROVAL BY CHINA MINISTRY OF COMMERCE, SOME OTHER CONDITIONS Source text for Eikon: Further company coverage:

23 Dec 2017

Becton, Dickinson agrees to divest two product lines for C R Bard buy -FTC

WASHINGTON, Dec 22 U.S. medical equipment supplier Becton Dickinson and C R Bard have agreed to divest two product lines to settle U.S. Federal Trade Commission charges that Becton, Dickinson's proposed $24 billion acquisition of Bard would negatively impact competition in those markets, the FTC said on Friday.

23 Dec 2017

Earnings vs. Estimates